Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal …

T Tan, WT Lim, KW Fong, SL Cheah, YL Soong… - International Journal of …, 2015 - Elsevier
Purpose To compare survival, tumor control, toxicities, and quality of life of patients with
locally advanced nasopharyngeal carcinoma (NPC) treated with induction chemotherapy …

[HTML][HTML] Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma

Z Chen, XH Xu - Saudi Medical Journal, 2015 - ncbi.nlm.nih.gov
Radiation therapy is the primary treatment in nasopharyngeal carcinoma (NPC), and the
effect of radiation therapy is strongly related to the oxygen content of cancer cells. That …

[HTML][HTML] Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal …

C Tang, F Wu, R Wang, H Lu, G Li, M Liu… - American Journal of …, 2016 - ncbi.nlm.nih.gov
Nasopharyngeal carcinoma (NPC) is highly incident in southern China. Metastasis is the
major cause of death in NPC patients. Concurrent chemoradiotherapy (CCRT) has been …

Nasopharyngeal carcinoma in children: Multimodal treatment and long‐term outcome of 92 patients in a single center over a 28‐year period

R Kebudi, SB Buyukkapu, O Gorgun… - Pediatric Blood & …, 2021 - Wiley Online Library
Objectives The aim of the study was to evaluate the long‐term outcome and late effects in
pediatric patients with nasopharyngeal carcinoma (NPC) treated with neoadjuvant …

Role of sequential chemoradiotherapy in stage II and low-risk stage III–IV nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a propensity …

C Xu, R Sun, LL Tang, L Chen, WF Li, YP Mao… - Oral oncology, 2018 - Elsevier
Objectives To investigate the role of sequential chemoradiotherapy (SCRT; induction
chemotherapy [IC] followed by intensity-modulated radiotherapy [IMRT]) in stage II and low …

[HTML][HTML] Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity …

F Wang, C Jiang, L Wang, F Yan, Q Sun, Z Ye, T Liu… - Scientific Reports, 2020 - nature.com
Neoadjuvant chemotherapy (NAC) combined with intensity-modulated radiotherapy (IMRT)
plus concurrent chemotherapy (CC) will be the new standard treatment for locoregionally …

Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer

S Okano, T Enokida, T Onoe, Y Ota, A Motegi… - International Journal of …, 2019 - Springer
Background In treatment of locally advanced squamous cell carcinoma of the head and neck
(SCCHN), the use of docetaxel, cisplatin, and 5-fluorouracil (TPF) followed by high-dose …

[HTML][HTML] Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma …

SY Wu, YH Wu, MW Yang, WT Hsueh, JR Hsiao… - BMC cancer, 2014 - Springer
Background Combined radiotherapy and chemotherapy is considered the standard of care
for locally advanced nasopharyngeal carcinoma (LA-NPC) in Epstein-Barr virus infection …

[HTML][HTML] Mechanistic study of tetrahydrofuran-acetogenins in triggering endoplasmic reticulum stress response-apotoposis in human nasopharyngeal carcinoma

SH Juang, CY Chiang, FP Liang, HH Chan, JS Yang… - Scientific reports, 2016 - nature.com
For past three decades, numerous studies have elucidated the antiproliferative effects of
acetogenins in hopes of developing a new class of clinical anticancer agents. However …

[HTML][HTML] Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosis

MB Cai, XP Wang, JX Zhang, HQ Han, CC Liu… - Journal of translational …, 2012 - Springer
Background Heat shock protein 70, a stress protein, has been implicated in tumor
progression. However, its role in nasopharyngeal carcinoma (NPC) progression has not yet …